Advantages And Disadvantages Of Genomics

   The Human Genome Project is the largest scientific endeavor undertaken since the Manhattan Project, and, as with the Manhattan Project, the completion of the Human Genome Project has brought to surface many moral and ethical issues concerning the use of the knowledge gained from the project. Although genetic tests for certain diseases have been available for 15 years (Ridley, 1999), the completion of the Human Genome Project will certainly lead to an exponential increase in the number of genetic tests available. Therefore, before genetic testing becomes a routine part of a visit to a doctor's office, the two main questions at the heart of the controversy surrounding genetic testing must be

Technology can be amazing if used in the right way and not used to harm people. The genome project leaves endless results of what is achievable through technology. Could someday, someone build an entire human from xenotransplantation. Could someday, there be a drug where you will never die anymore. The life expectancy from the last one hundred has already risen fifty percent to seventy-five years due to medicine. Who says this can’t keep growing now that it’s almost possible to have a xenotransplantation where you could get a “brand new heart or lungs that were grown in a pig.” Also, the fact that we can now predict what disease a baby is going to or can have by ten weeks after they are conceived, makes me wonder are we ever going to have worry about getting a surprise new health condition in our life.

The inclusion of genetic testing into Electronic Health Records impacts the overall healthcare of patient’s because it informs the physicians and other medical professionals the selection of effective treatment or preventive action. A manager’s responsibilities are to implement policies to protect the confidentiality, privacy, and security of genetic tests results and information of patient’s. Policies contributing to potential discrimination acts are also advised because genetic/genomic testing reveals a patient’s physical characteristics.

Genetic testing has become a highly controversial issue among both the general population and the scientific community. It is a process that exposes a person’s entire genome sequence, allowing it to be read and evaluated to identify potential risks for genetic diseases or diseases that could be passed onto offspring (Holt Productions, 2012). With thousands of genetic tests already being used, and more being established, it seems logical to put this growing technology to use. Some agree that it is a person’s right to know and understand his or her genetic makeup. However, others argue that, despite the benefits of genetic testing, caution should be used to carefully inspect the risks associated with this new technology.

According to Chrystoja and Diamandis (2013), targeted genome testing is less costly than some traditional testing methods, is effective in assisting decision making for certain neoplastic medications and is useful in guiding the proper testing for certain diseases such as Lynch Syndrome. In addition, genetic makeup determines the pharmacokinetics of certain drugs and genome testing may assist in medication therapies. Studies indicate that genetic predisposition determines the effectiveness of 20% to 95% of prescribed medications (Bartlett, 2011). With DNA information, a physician can prescribe a tailored medication treatment that will benefit the

<br>4. The rights of knowing someone's own health status and keeping that information private to oneself should be provided to all members of a society. Only the individual should have full access to information about his own genetic constitution and others should be prevented by legal regulations. As we have said above, the results of genetic tests can sometimes be detrimental to the individual. If a person does not want to know the information, its nobody's business nor right to declare it. This includes even not explaining favorable test results without the individual's request.

In recent discussions of medical advancements, a controversial issue has been genome mapping poses risks to its patients. On the one hand, some argue that it is going to be time consuming and costly. On the other hand, however, others argue that this can be a breakthrough in medicine. In sum, then, the issue is what America’s next step towards medical advancement is going to be. While some believe genome mapping poses many unseen risks, genetic testing can help identify unsurfaced illnesses.

Before discussion of the ethical, legal and social issues can be successful, some background information is needed. For example, why is the goal of mapping the human genome important? Who is going to benefit or at least be affected by this new

When people experience genetic tests, privacy incorporates the privilege to make an educated, free choice about whether others may know points of interest of their genome, e.g., insurance, businesses, instructive foundations, spouses and other relatives, scientists, and social agencies. This incorporates a privilege to settle on certain conceptive decisions, for example, regardless of whether to utilize genetic testing. It likewise incorporates a privilege to reject treatment. A couple of court choices discover security for such data under the established precept of security, yet more ordinarily, security assurance against revelation of individual data is found under customary law tort principle. (7) Moreover, there is a federal privacy act, (8) and in addition state statutes ensuring

Although the gene chip will enable an individual to know whether he/she has a genetic disease, that person may not want to know the information. Many people are frightened that a positive finding on a genetic test will result in discrimination and ostracism because the society will consider them abnormal (Easthope 2005). The other concern is that with genetic test information one might lose or might be unable to get a job or insurance. There have been concerns that with the knowledge of one’s medical information after a gene test, he/she might suffer a psychological problem especially when the results reveal that one suffers from a terminal disease or has high possibility of suffering from one (Willis 2009).

There were approximately 300 genetic tests available that time. It is significant to note that the reference sequence of human genome was completed by Scientists in April 2003 (Hudson et al, 2008) and current genetic tests encompass over 1500 conditions. Barclay and Markell (2007) explained the ability to establish and document a person’s genetic composition is known as genetic mapping. It must be noted that genetic mapping was achieved through the Human Genome Project (HGP) as a collaborative international research program (Barclay & Markell, 1999). Genetic information was considered to be adequately different from other health related information thus the need for special legal protection (Ginsburg,

The sequencing of the human genome has a new approach to health care in regards to promotion, maintenance, and treatment. Genetic research is defined as a new approach to a better understanding of the genetic components of common diseases: Cancer, diabetes, stroke, and creating new gene-based technologies for screening, prevention, diagnosis, and treatment of both rare and common diseases. Nurses are a main aspect within the first line of care, and therefore will contribute fully in genetic-based and genomic-based practice activities such as collecting family history, obtaining informed consent for genetic testing, and administering gene-based therapies. Lea, D, (January 31, 2008). My paper is based on an article Genomics in the public

genetic testing, everything has changed. She notes that clinicians now have the ability to diagnose, treat, and monitor a patient’s illnesses or disease progression in an entirely different manner. This is a far cry from the old medical model of responding to a disease (or defect) only after it appears, and then prescribing the recommended medication or intervention. These genetic medical advances sound miraculous and promising, but the ability to test, screen and provide early intervention does not come without many major ethical dilemmas.

The fear of genetic discrimination is a phobia gripping many people around the world. People find themselves asking, could my genetic information raise my health bills? Could this cause me to be rejected from a job opportunity? These anxieties are causing people to lash out at genetic research, and ultimately the human genome project. People do not want our understanding of human genomics to advance. This is because the risks of the development of the technology could inflict on them. A major risk is genetic discrimination. I believe that genetic discrimination is wrong and governments should continue to prevent it because it is an invasion of privacy, it violates equity, and it could really hurt people with genetic

The participants will only be enrolled after participating in an informed consent process. The participants have a choice on whether they want to receive the information or not. The focus of the study is to determine how clinicians and families use the genomic sequence results in their decision making. If a family wishes not to know their sequence information they do not have to participant. The technological advances in DNA sequencing have made high throughout sequencing methods faster and cheaper. In contrast this allows researchers to generate larger datasets to be used for genome wide association studies to identify specific factors associated with human health and disease.